Japan Tissue Engineering CoTSE:7774 +2.54%60 Days Inventory is 88.09 as of Mar. 2026, which is 25% above its 10-year median of 70.33. GuruFocus rates TSE:7774 with a GF Score™ of 60/100 and a GF Value™ of 円517.24 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 637 Biotechnology companies, Japan Tissue Engineering Co ranks better than 76.61% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Japan Tissue Engineering Co's Inventory Turnover for the
six
months ended in Mar. 2026 was 2.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Japan Tissue Engineering Co's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.19.
Japan Tissue Engineering Co (TSE:7774) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Japan Tissue Engineering Co's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Japan Tissue Engineering Co's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Japan Tissue Engineering Co Days Inventory Related Terms
Japan Tissue Engineering Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7774 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Japan Tissue Engineering Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Tissue Engineering Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Japan Tissue Engineering Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Tissue Engineering Co (TSE:7774) has a Days Inventory of 88.09 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Japan Tissue Engineering Co and its competitors. This is 25% above median its historical median of 70.33. Over the past decade, Japan Tissue Engineering Co's Days Inventory has ranged from 45.74 to 103.31. According to the industry distribution chart, Japan Tissue Engineering Co ranks #149 out of 637 companies in the Biotechnology industry, placing it in the top 23.4%.
Is Japan Tissue Engineering Co's Days Inventory too high?
Japan Tissue Engineering Co's current Days Inventory of 88.09 is 25% above median its 10-year median of 70.33. Over the past 10 years, this metric has ranged from a low of 45.74 to a high of 103.31. The Biotechnology industry median Days Inventory is 183.23. Japan Tissue Engineering Co's value of 88.09 is 51.9% below this industry median. Based on the distribution chart, Japan Tissue Engineering Co ranks #149 out of 637 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Tissue Engineering Co has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Japan Tissue Engineering Co ranks #149 out of 637 companies for Days Inventory. This places Japan Tissue Engineering Co in the top 23% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. Japan Tissue Engineering Co's value of 88.09 is 51.9% below this benchmark. Historically, Japan Tissue Engineering Co's own Days Inventory has ranged from 45.74 to 103.31 over the past decade. While the company's 10-year median is 70.33 vs. the industry median of 183.23, Japan Tissue Engineering Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Tissue Engineering Co's current Days Inventory of 88.09 is 51.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Japan Tissue Engineering Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Tissue Engineering Co's current Days Inventory is 88.09, which is 25% above median its own 10-year median of 70.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Modestly Overvalued. The stock's GF Value™ is 円517.24, compared to a current price of 円646.00 — trading 24.9% above its estimated fair value. The current Days Inventory is 88.09, which is 25% above median its 10-year median of 70.33 and 51.9% below the Biotechnology industry median of 183.23. Japan Tissue Engineering Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current Days Inventory is 88.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued.
The current stock price of 円646.00 is trading 24.9% above its estimated GF Value™ of 円517.24.
GuruFocus considers Japan Tissue Engineering Co to be Modestly Overvalued.
Key valuation signals for TSE:7774:
Days Inventory: 88.09 (25% above median its 10-year median of 70.33)
GF Value™: 円517.24 vs. price of 円646.00 (24.9% above fair value)
Industry Position: 51.9% below the Biotechnology median (#149 of 637)
No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
60GF Score
Get the complete analysis for TSE:7774
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7774 has been successfully added to your 
